Facebook loses gains sparked by Zuckerberg Shares down

New Post Public Reply Private Reply Replies (0) Message Board
FLA

Facebook loses gains sparked by Zuckerberg


Shares down 15% since CEO touted mobile-ad gains at conference       10/10 11:32 AM



SAN FRANCISCO (MarketWatch) -- Facebook Inc. (FB:$19.7383,$-0.4887,-2.42%) slumped Wednesday, adding to a recent string of losses that has seen the social network's shares give up nearly all of the gains that were sparked by comments from CEO Mark Zuckerberg a month ago.
By midmorning trades, Facebook (FB:$19.7383,$-0.4887,-2.42%) shares were off by 2.3% to $19.76 -- having lost more than 3.5% earlier in the session.
A few factors weighed on the stock Wednesday. A pair of brokerage notes expressed continued caution over the company's mobile ad business. Credit Suisse cut its price target on the stock to $24 from $34, keeping its rating at neutral.
"We remain on the sidelines given the lockup expiration, mobile challenges, and the nascent stage of ROI [return on investment] measurement on the platform," wrote analyst Stephen Ju of Credit Suisse.
Also, an article by Bloomberg reported that regulators with the Securities and Exchange Commission had pressed the company for greater disclosure on the risks related to its mobile and desktop ad businesses just days before its controversial IPO on May 18.
The social network has been on a roller coaster for the past month. Zuckerberg lit up the stock with his comments at the TechCrunch Disrupt conference in San Francisco on Sept. 11, sparking an upswing that added more than 24% to the shares over the following week.
In what amounted to his first public appearance since the company's controversial IPO, Zuckerberg made several positive comments about the company's mobile ad business, which analysts believe is key to the company's growth, given slowing usage of Facebook (FB:$19.7383,$-0.4887,-2.42%) through desktop computers.
Facebook's (FB:$19.7383,$-0.4887,-2.42%) shares have largely remained above the $20 mark since then, but a downtick began last week after Zuckerberg touted that the company passed the milestone of having 1 billion monthly active users. See: Facebook (FB:$19.7383,$-0.4887,-2.42%) hits 1 billion users
The stock has come down more than 9% since Zuckerberg's disclosure last week -- and 15% since its closing price on Sept. 19 following the run-up that was sparked by Zuckerberg's comments at TechCrunch.

Facebook's (FB:$19.7383,$-0.4887,-2.42%) mobile ad business remains a key concern for investors. In a note to clients on Wednesday, Jason Helfstein of Oppenheimer noted a slowdown in Facebook's (FB:$19.7383,$-0.4887,-2.42%) desktop usage in September, as measured by comScore. The social network saw a 20% decline in desktop usage in September compared with the same month last year -- an acceleration from the 14% drop shown in August.
Helfstein concluded that the metrics indicate that Wall Street's estimates "remain too high for 2013," though he continues to rate the stock as an outperform.
Ju of Credit Suisse says he also has a "positive long-term bias" on Facebook (FB:$19.7383,$-0.4887,-2.42%) , based on its "user scale." He believes the "network effect" of this scale will give the company a competitive advantage. Facebook (FB:$19.7383,$-0.4887,-2.42%) will report its next quarterly results on Oct. 23.


Get more news on:SYMBOLS: FBNEWS TYPE: Company News, Top News, Top Stories: General, Top Stories: Investing, CommoditiesSECTORS: Consumer Discretionary, Media, Information Technology, Communications Equipment, Computers and Peripherals, Internet Software and Services, IT Services, Software

I ONLY POST WHAT I PLAY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

IVD Reagents Market Growth Expected to Reach $55.3 Billion

Updated Category News Views 120

Growth Forecast for the IVD Reagents Market The global In Vitro Diagnostic (IVD) reagents market is on an impressive trajectory to reach nearly USD 55.3 billion by 2029. The demand for IVD reagents has surged, driven by numerous factors such as a rising prevalence of chronic and infectious diseases, alongside a growing emphasis on preventive healthcare. In 2022, the IVD...

Continue Reading
Cayuga Centers Expands Leadership Team with New Appointments

Updated Category News Views 235

Exciting Growth at Cayuga Centers With New Board Members Cayuga Centers is thrilled to announce the welcoming of nine new members to its Board of Trustees. This addition of distinguished professionals promises to enhance the agency's leadership and the resources it employs to support children, youth, and families across the nation. Each of these new board members brings a...

Continue Reading
Elements Massage Celebrates Skin Care Awareness Month with Tips

Updated Category News Views 204

Elements Massage Celebrates National Skin Care Awareness Month As National Skin Care Awareness Month comes to an end, Elements Massage, the nation's leading massage therapy concept, is highlighting skincare and wellness. Innovative Skincare Services Elements Massage has introduced enhanced skincare services in collaboration with Sanitas Skincare. This partnership marks...

Continue Reading
The Growth Journey of Danaher Stock Over the Past Decade

Updated Category News Views 106

Understanding Danaher's Stock Growth Danaher Corporation (NYSE: DHR) has consistently demonstrated robust performance in the stock market. With an average annual return of 13.82%, it has outpaced the market by 1.08% over the past decade. Currently, Danaher boasts a commendable market capitalization of $163.05 billion. Investment Insight: What If You Invested $100? Let’s...

Continue Reading
Matthew A. Cartwright Returns to Munley Law to Elevate Advocacy

Updated Category News Views 197

Matthew A. Cartwright Rejoins Munley Law as Of Counsel The six-term Congressman brings decades of legal expertise and legislative accomplishments back to the Pennsylvania personal injury law firm. MUNLEY Law is excited to announce the return of former U.S. Representative Matthew A. Cartwright as Of Counsel. Following a commendable 12 years in Congress, Cartwright brings a...

Continue Reading